The insulin paradox: aging, proteotoxicity and neurodegeneration (original) (raw)
Reichel, W. The biology of aging. J. Am. Geriatr. Soc.14, 431–436 (1966). CASPubMed Google Scholar
Bishop, N. A. & Guarente, L. Genetic links between diet and lifespan: shared mechanisms from yeast to humans. Nature Rev. Genet.8, 835–844 (2007). ArticleCASPubMed Google Scholar
Mair, W. & Dillin, A. Aging and survival: the genetics of life span extension by dietary restriction. Annu. Rev. Biochem.77, 727–754 (2008). CASPubMed Google Scholar
Kenyon, C., Chang, J., Gensch, E., Rudner, A. & Tabtiang, R. A C. elegans mutant that lives twice as long as wild type. Nature366, 461–464 (1993). CASPubMed Google Scholar
Giannakou, M. E. & Partridge, L. Role of insulin-like signalling in Drosophila lifespan. Trends Biochem. Sci.32, 180–188 (2007). CASPubMed Google Scholar
Tatar, M. et al. A mutant Drosophila insulin receptor homolog that extends life-span and impairs neuroendocrine function. Science292, 107–110 (2001). CASPubMed Google Scholar
Holzenberger, M. et al. IGF-1 receptor regulates lifespan and resistance to oxidative stress in mice. Nature421, 182–187 (2003). This study established that the longevity and stress-resistance effects of reduced IIS are conserved from invertebrates to mammals. CASPubMed Google Scholar
Russell, S. J. & Kahn, C. R. Endocrine regulation of ageing. Nature Rev. Mol. Cell Biol.8, 681–691 (2007). CAS Google Scholar
Taguchi, A., Wartschow, L. M. & White, M. F. Brain IRS2 signaling coordinates life span and nutrient homeostasis. Science317, 369–372 (2007). CASPubMed Google Scholar
Dillin, A. et al. Rates of behavior and aging specified by mitochondrial function during development. Science298, 2398–2401 (2002). CASPubMed Google Scholar
Lee, S. S. et al. A systematic RNAi screen identifies a critical role for mitochondria in C. elegans longevity. Nature Genet.33, 40–48 (2003). CASPubMed Google Scholar
Taguchi, A. & White, M. F. Insulin-like signaling, nutrient homeostasis, and life span. Annu. Rev. Physiol.70, 191–212 (2008). CASPubMed Google Scholar
Balch, W. E., Morimoto, R. I., Dillin, A. & Kelly, J. W. Adapting proteostasis for disease intervention. Science319, 916–919 (2008). CASPubMed Google Scholar
Aguilaniu, H., Gustafsson, L., Rigoulet, M. & Nystrom, T. Asymmetric inheritance of oxidatively damaged proteins during cytokinesis. Science299, 1751–1753 (2003). CASPubMed Google Scholar
Hebert, D. N. & Molinari, M. In and out of the ER: protein folding, quality control, degradation, and related human diseases. Physiol. Rev.87, 1377–1408 (2007). CASPubMed Google Scholar
Gidalevitz, T., Ben-Zvi, A., Ho, K. H., Brignull, H. R. & Morimoto, R. I. Progressive disruption of cellular protein folding in models of polyglutamine diseases. Science311, 1471–1474 (2006). In this article the authors reported that the expression of one aggregation-prone polyQ protein can destabilize the genome and lead to the aggregation of other proteins. CASPubMed Google Scholar
Kopito, R. R. & Ron, D. Conformational disease. Nature Cell Biol.2, E207–E209 (2000). CASPubMed Google Scholar
Selkoe, D. J. Folding proteins in fatal ways. Nature426, 900–904 (2003). CASPubMed Google Scholar
Bates, G. Huntingtin aggregation and toxicity in Huntington's disease. Lancet361, 1642–1644 (2003). CASPubMed Google Scholar
Caughey, B. & Lansbury, P. T. Protofibrils, pores, fibrils, and neurodegeneration: separating the responsible protein aggregates from the innocent bystanders. Annu. Rev. Neurosci.26, 267–298 (2003). CASPubMed Google Scholar
Haass, C. & Selkoe, D. J. Soluble protein oligomers in neurodegeneration: lessons from the Alzheimer's amyloid b-peptide. Nature Rev. Mol. Cell Biol.8, 101–112 (2007). CAS Google Scholar
Forloni, G. Neurotoxicity of beta-amyloid and prion peptides. Curr. Opin. Neurol.9, 492–500 (1996). CASPubMed Google Scholar
Kim, S. J. & Linden, D. J. Ubiquitous plasticity and memory storage. Neuron56, 582–592 (2007). CASPubMed Google Scholar
Shankar, G. M. et al. Amyloid-β protein dimers isolated directly from Alzheimer's brains impair synaptic plasticity and memory. Nature Med. 22 Jun 2008 (doi:10.1038/nm1782). CASPubMedPubMed Central Google Scholar
Townsend, M., Shankar, G. M., Mehta, T., Walsh, D. M. & Selkoe, D. J. Effects of secreted oligomers of amyloid β-protein on hippocampal synaptic plasticity: a potent role for trimers. J. Physiol.572, 477–492 (2006). CASPubMedPubMed Central Google Scholar
Arrasate, M., Mitra, S., Schweitzer, E. S., Segal, M. R. & Finkbeiner, S. Inclusion body formation reduces levels of mutant huntingtin and the risk of neuronal death. Nature431, 805–810 (2004). CASPubMed Google Scholar
Behrends, C. et al. Chaperonin TRiC promotes the assembly of polyQ expansion proteins into nontoxic oligomers. Mol. Cell23, 887–897 (2006). Along with reference 28, this work indicated that chaperones, which are known to disrupt protein aggregates, switch to actively create aggregates of high molecular mass when the concentration of the aggregating protein is high. These papers thus established the idea that active aggregation can be protective. CASPubMed Google Scholar
Shorter, J. & Lindquist, S. Hsp104 catalyzes formation and elimination of self-replicating Sup35 prion conformers. Science304, 1793–1797 (2004). CASPubMed Google Scholar
Amaducci, L. & Tesco, G. Aging as a major risk for degenerative diseases of the central nervous system. Curr. Opin. Neurol.7, 283–286 (1994). CASPubMed Google Scholar
Brignull, H. R., Morley, J. F. & Morimoto, R. I. The stress of misfolded proteins: C. elegans models for neurodegenerative disease and aging. Adv. Exp. Med. Biol.594, 167–189 (2007). PubMed Google Scholar
Jankowsky, J. L. et al. Transgenic mouse models of neurodegenerative disease: opportunities for therapeutic development. Curr. Neurol. Neurosci. Rep.2, 457–464 (2002). PubMed Google Scholar
Cohen, E., Bieschke, J., Perciavalle, R. M., Kelly, J. W. & Dillin, A. Opposing activities protect against age-onset proteotoxicity. Science313, 1604–1610 (2006). CASPubMed Google Scholar
Hsu, A. L., Murphy, C. T. & Kenyon, C. Regulation of aging and age-related disease by DAF-16 and heat-shock factor. Science300, 1142–1145 (2003). This paper showed that HSF-1 is crucial for enabling reduced IIS to extend lifespan. CASPubMed Google Scholar
Morley, J. F., Brignull, H. R., Weyers, J. J. & Morimoto, R. I. The threshold for polyglutamine-expansion protein aggregation and cellular toxicity is dynamic and influenced by aging in Caenorhabditis elegans. Proc. Natl Acad. Sci. USA99, 10417–10422 (2002). This seminal study indicated that the minimal number of polyQ repeats that is needed to enable aggregation declines with age. It also showed that a reduction in IIS protects worms from polyQ aggregation. PubMedPubMed Central Google Scholar
Kimura, K. D., Tissenbaum, H. A., Liu, Y. & Ruvkun, G. daf-2, an insulin receptor-like gene that regulates longevity and diapause in Caenorhabditis elegans. Science277, 942–946 (1997). CASPubMed Google Scholar
Morris, J. Z., Tissenbaum, H. A. & Ruvkun, G. A phosphatidylinositol-3-OH kinase family member regulating longevity and diapause in Caenorhabditis elegans. Nature382, 536–539 (1996). CASPubMed Google Scholar
Kops, G. J. et al. Direct control of the Forkhead transcription factor AFX by protein kinase B. Nature398, 630–634 (1999). CASPubMed Google Scholar
Paradis, S. & Ruvkun, G. Caenorhabditis elegans Akt/PKB transduces insulin receptor-like signals from AGE-1 PI3 kinase to the DAF-16 transcription factor. Genes Dev.12, 2488–2498 (1998). CASPubMedPubMed Central Google Scholar
Ogg, S. & Ruvkun, G. The C. elegans PTEN homolog, DAF-18, acts in the insulin receptor-like metabolic signaling pathway. Mol. Cell2, 887–893 (1998). CASPubMed Google Scholar
Henderson, S. T. & Johnson, T. E. daf-16 integrates developmental and environmental inputs to mediate aging in the nematode Caenorhabditis elegans. Curr. Biol.11, 1975–1980 (2001). CASPubMed Google Scholar
Lee, R. Y., Hench, J. & Ruvkun, G. Regulation of C. elegans DAF-16 and its human ortholog FKHRL1 by the daf-2 insulin-like signaling pathway. Curr. Biol.11, 1950–1957 (2001). CASPubMed Google Scholar
Murphy, C. T. et al. Genes that act downstream of DAF-16 to influence the lifespan of Caenorhabditis elegans. Nature424, 277–283 (2003). CASPubMed Google Scholar
Kenyon, C. The plasticity of aging: insights from long-lived mutants. Cell120, 449–460 (2005). CASPubMed Google Scholar
Bluher, M., Kahn, B. B. & Kahn, C. R. Extended longevity in mice lacking the insulin receptor in adipose tissue. Science299, 572–574 (2003). PubMed Google Scholar
Suh, Y. et al. Functionally significant insulin-like growth factor I receptor mutations in centenarians. Proc. Natl Acad. Sci. USA105, 3438–3442 (2008). This report indicated that reduced IGF signalling is typical in the offspring of centenarians and suggested that the regulation of lifespan by IGF signalling is conserved in humans. It also showed that high IGF plasma levels can lead to reduced IGF signalling, supporting the idea that feedback loops regulate the IIS pathway. CASPubMedPubMed Central Google Scholar
Morley, J. F. & Morimoto, R. I. Regulation of longevity in Caenorhabditis elegans by heat shock factor and molecular chaperones. Mol. Biol. Cell15, 657–664 (2004). CASPubMedPubMed Central Google Scholar
Liu, X. D., Liu, P. C., Santoro, N. & Thiele, D. J. Conservation of a stress response: human heat shock transcription factors functionally substitute for yeast HSF. EMBO J.16, 6466–6477 (1997). CASPubMedPubMed Central Google Scholar
Rabindran, S. K., Haroun, R. I., Clos, J., Wisniewski, J. & Wu, C. Regulation of heat shock factor trimer formation: role of a conserved leucine zipper. Science259, 230–234 (1993). CASPubMed Google Scholar
Walker, G. A., Thompson, F. J., Brawley, A., Scanlon, T. & Devaney, E. Heat shock factor functions at the convergence of the stress response and developmental pathways in Caenorhabditis elegans. FASEB J.17, 1960–1962 (2003). CASPubMed Google Scholar
Sarge, K. D., Murphy, S. P. & Morimoto, R. I. Activation of heat shock gene transcription by heat shock factor 1 involves oligomerization, acquisition of DNA-binding activity, and nuclear localization and can occur in the absence of stress. Mol. Cell. Biol.13, 1392–1407 (1993). CASPubMedPubMed Central Google Scholar
Baird, N. A., Turnbull, D. W. & Johnson, E. A. Induction of the heat shock pathway during hypoxia requires regulation of heat shock factor by hypoxia-inducible factor-1. J. Biol. Chem.281, 38675–38681 (2006). CASPubMed Google Scholar
Reinke, H. et al. Differential display of DNA-binding proteins reveals heat-shock factor 1 as a circadian transcription factor. Genes Dev.22, 331–345 (2008). CASPubMedPubMed Central Google Scholar
Singh, V. & Aballay, A. Heat-shock transcription factor (HSF)-1 pathway required for Caenorhabditis elegans immunity. Proc. Natl Acad. Sci. USA103, 13092–13097 (2006). CASPubMedPubMed Central Google Scholar
Bishop, N. A. & Guarente, L. Two neurons mediate diet-restriction-induced longevity in C. elegans. Nature447, 545–549 (2007). CASPubMed Google Scholar
Tullet, J. M. et al. Direct inhibition of the longevity-promoting factor SKN-1 by insulin-like signaling in C. elegans. Cell132, 1025–1038 (2008). CASPubMedPubMed Central Google Scholar
McElwee, J., Bubb, K. & Thomas, J. H. Transcriptional outputs of the Caenorhabditis elegans forkhead protein DAF-16. Aging Cell2, 111–121 (2003). CASPubMed Google Scholar
Halaschek-Wiener, J. et al. Analysis of long-lived C. elegans daf-2 mutants using serial analysis of gene expression. Genome Res.15, 603–615 (2005). CASPubMedPubMed Central Google Scholar
Oh, S. W. et al. Identification of direct DAF-16 targets controlling longevity, metabolism and diapause by chromatin immunoprecipitation. Nature Genet.38, 251–257 (2006). PubMed Google Scholar
Dong, M. Q. et al. Quantitative mass spectrometry identifies insulin signaling targets in C. elegans. Science317, 660–663 (2007). CASPubMed Google Scholar
Tonkiss, J. & Calderwood, S. K. Regulation of heat shock gene transcription in neuronal cells. Int. J. Hyperthermia21, 433–444 (2005). CASPubMed Google Scholar
Hartl, F. U. & Hayer-Hartl, M. Molecular chaperones in the cytosol: from nascent chain to folded protein. Science295, 1852–1858 (2002). CASPubMed Google Scholar
Barral, J. M., Broadley, S. A., Schaffar, G. & Hartl, F. U. Roles of molecular chaperones in protein misfolding diseases. Semin. Cell Dev. Biol.15, 17–29 (2004). CASPubMed Google Scholar
Howitz, K. T. et al. Small molecule activators of sirtuins extend Saccharomyces cerevisiae lifespan. Nature425, 191–196 (2003). CASPubMed Google Scholar
Wood, J. G. et al. Sirtuin activators mimic caloric restriction and delay ageing in metazoans. Nature430, 686–689 (2004). CASPubMed Google Scholar
Valenzano, D. R. et al. Resveratrol prolongs lifespan and retards the onset of age-related markers in a short-lived vertebrate. Curr. Biol.16, 296–300 (2006). CASPubMed Google Scholar
Parker, J. A. et al. Resveratrol rescues mutant polyglutamine cytotoxicity in nematode and mammalian neurons. Nature Genet.37, 349–350 (2005). This study showed that altering aging with the drug Resveratrol protects PolyQ-expressing neurons from protein aggregation. It thus linked the aging process and protein-aggregation neurotoxicity. CASPubMed Google Scholar
Tissenbaum, H. A. & Guarente, L. Increased dosage of a sir-2 gene extends lifespan in Caenorhabditis elegans. Nature410, 227–230 (2001). CASPubMed Google Scholar
Link, C. Expression of human β-amyloid peptide in transgenic Caenorhabditis elegans. Proc. Natl Acad. Sci. USA92, 9368–9372 (1995). CASPubMedPubMed Central Google Scholar
Humbert, S. et al. The IGF-1/Akt pathway is neuroprotective in Huntington's disease and involves Huntingtin phosphorylation by Akt. Dev. Cell2, 831–837 (2002). CASPubMed Google Scholar
Yamamoto, A., Cremona, M. L. & Rothman, J. E. Autophagy-mediated clearance of huntingtin aggregates triggered by the insulin-signaling pathway. J. Cell Biol.172, 719–731 (2006). CASPubMedPubMed Central Google Scholar
Carro, E., Trejo, J. L., Gomez-Isla, T., LeRoith, D. & Torres-Aleman, I. Serum insulin-like growth factor I regulates brain amyloid-β levels. Nature Med.8, 1390–1397 (2002). CASPubMed Google Scholar
Carro, E. et al. Therapeutic actions of insulin-like growth factor I on APP/PS2 mice with severe brain amyloidosis. Neurobiol. Aging27, 1250–1257 (2006). CASPubMed Google Scholar
Gasparini, L. & Xu, H. Potential roles of insulin and IGF-1 in Alzheimer's disease. Trends Neurosci.26, 404–406 (2003). CASPubMed Google Scholar
Bonkowski, M. S., Rocha, J. S., Masternak, M. M., Al Regaiey, K. A. & Bartke, A. Targeted disruption of growth hormone receptor interferes with the beneficial actions of calorie restriction. Proc. Natl Acad. Sci. USA103, 7901–7905 (2006). CASPubMedPubMed Central Google Scholar
Tomlinson, D. R. & Gardiner, N. J. Glucose neurotoxicity. Nature Rev. Neurosci.9, 36–45 (2008). CAS Google Scholar
Zick, Y. Ser/Thr phosphorylation of IRS proteins: a molecular basis for insulin resistance. Sci. STKE pe4 (2005). Google Scholar
George, S. et al. A family with severe insulin resistance and diabetes due to a mutation in AKT2. Science304, 1325–1328 (2004). CASPubMedPubMed Central Google Scholar
Biddinger, S. B. et al. Hepatic insulin resistance is sufficient to produce dyslipidemia and susceptibility to atherosclerosis. Cell. Metab.7, 125–134 (2008). CASPubMedPubMed Central Google Scholar
Brown, M. S. & Goldstein, J. L. Selective versus total insulin resistance: a pathogenic paradox. Cell. Metab.7, 95–96 (2008). CASPubMed Google Scholar
Michael, M. D. et al. Loss of insulin signaling in hepatocytes leads to severe insulin resistance and progressive hepatic dysfunction. Mol. Cell6, 87–97 (2000). CASPubMed Google Scholar
Craft, S. et al. Cerebrospinal fluid and plasma insulin levels in Alzheimer's disease: relationship to severity of dementia and apolipoprotein E genotype. Neurology50, 164–168 (1998). This study indicated that insulin levels can vary in the plasma and in the CSF, and it correlated these levels with severity of dementia in Alzheimer's disease. Google Scholar
Teede, H. J., Hutchison, S., Zoungas, S. & Meyer, C. Insulin resistance, the metabolic syndrome, diabetes, and cardiovascular disease risk in women with PCOS. Endocrine30, 45–53 (2006). CASPubMed Google Scholar
Walker, D. W., McColl, G., Jenkins, N. L., Harris, J. & Lithgow, G. J. Evolution of lifespan in C. elegans. Nature405, 296–297 (2000). CASPubMed Google Scholar
Golden, J. W. & Riddle, D. L. The Caenorhabditis elegans dauer larva: developmental effects of pheromone, food and temperature. Dev. Biol.102, 368–378 (1984). CASPubMed Google Scholar
Holzenberger, M. et al. Experimental IGF-I receptor deficiency generates a sexually dimorphic pattern of organ-specific growth deficits in mice, affecting fat tissue in particular. Endocrinology142, 4469–4478 (2001). CASPubMed Google Scholar
Patel, D. S. et al. Clustering of genetically defined allele classes in the Caenorhabditis elegans DAF-2 insulin/IGF-1 receptor. Genetics178, 931–946 (2008). CASPubMedPubMed Central Google Scholar
Leibson, C. L. et al. The risk of dementia among persons with diabetes mellitus: a population-based cohort study. Ann. NY Acad. Sci.826, 422–427 (1997). CASPubMed Google Scholar
Ott, A. et al. Diabetes mellitus and the risk of dementia: The Rotterdam Study. Neurology53, 1937–1942 (1999). CASPubMed Google Scholar
Dillin, A., Crawford, D. K. & Kenyon, C. Timing requirements for insulin/IGF-1 signaling in C. elegans. Science298, 830–834 (2002). CASPubMed Google Scholar
McCay, C. M., Crowell, M. F. & Maynard, L. A. The effect of retarded growth upon the length of life span and upon the ultimate body size. 1935. Nutrition5, 155–171; discussion 172 (1989). CASPubMed Google Scholar
Lin, S. J. et al. Calorie restriction extends Saccharomyces cerevisiae lifespan by increasing respiration. Nature418, 344–348 (2002). CASPubMed Google Scholar
Klass, M. R. Aging in the nematode Caenorhabditis elegans: major biological and environmental factors influencing life span. Mech. Ageing Dev.6, 413–429 (1977). CASPubMed Google Scholar
Partridge, L., Piper, M. D. & Mair, W. Dietary restriction in Drosophila. Mech. Ageing Dev.126, 938–950 (2005). CASPubMed Google Scholar
Mair, W., Piper, M. D. & Partridge, L. Calories do not explain extension of life span by dietary restriction in Drosophila. PLoS Biol.3, e223 (2005). PubMedPubMed Central Google Scholar
Panowski, S. H., Wolff, S., Aguilaniu, H., Durieux, J. & Dillin, A. PHA-4/Foxa mediates diet-restriction-induced longevity of C. elegans. Nature447, 550–555 (2007). CASPubMed Google Scholar
Larsen, P. L., Albert, P. S. & Riddle, D. L. Genes that regulate both development and longevity in Caenorhabditis elegans. Genetics139, 1567–1583 (1995). CASPubMedPubMed Central Google Scholar
Honda, Y. & Honda, S. The daf-2 gene network for longevity regulates oxidative stress resistance and Mn-superoxide dismutase gene expression in Caenorhabditis elegans. FASEB J.13, 1385–1393 (1999). CASPubMed Google Scholar
Lithgow, G. J., White, T. M., Melov, S. & Johnson, T. E. Thermotolerance and extended life-span conferred by single-gene mutations and induced by thermal stress. Proc. Natl Acad. Sci. USA92, 7540–7544 (1995). CASPubMedPubMed Central Google Scholar
Pinkston, J. M., Garigan, D., Hansen, M. & Kenyon, C. Mutations that increase the life span of C. elegans inhibit tumor growth. Science313, 971–975 (2006). CASPubMed Google Scholar
Pinkston-Gosse, J. & Kenyon, C. DAF-16/FOXO targets genes that regulate tumor growth in Caenorhabditis elegans. Nature Genet.39, 1403–1409 (2007). CASPubMed Google Scholar
Hightower, L. E. Heat shock, stress proteins, chaperones, and proteotoxicity. Cell66, 191–197 (1991). CASPubMed Google Scholar
Outeiro, T. F. et al. Sirtuin 2 inhibitors rescue α-synuclein-mediated toxicity in models of Parkinson's disease. Science317, 516–519 (2007). CASPubMed Google Scholar
Bossy-Wetzel, E., Schwarzenbacher, R. & Lipton, S. A. Molecular pathways to neurodegeneration. Nature Med.10 (Suppl.), S2–S9 (2004). PubMed Google Scholar
Muchowski, P. J. & Wacker, J. L. Modulation of neurodegeneration by molecular chaperones. Nature Rev. Neurosci.6, 11–22 (2005). CAS Google Scholar